As we show in Table 1, for the main purpose of comparing the three techniques, we selected a small pilot cohort of a total of eight LUAD and CRC samples for this analysis due to their high population prevalence but, more importantly, because both tumor types can harbor the BRAF p.V600E mutation. The gene discussed is BRAF; the disease is neoplasm.